Panacea Biotec Ltd
NSE:PANACEABIO

Watchlist Manager
Panacea Biotec Ltd Logo
Panacea Biotec Ltd
NSE:PANACEABIO
Watchlist
Price: 433.25 INR 0.97% Market Closed
Market Cap: 26.5B INR
Have any thoughts about
Panacea Biotec Ltd?
Write Note

Panacea Biotec Ltd
Short-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Panacea Biotec Ltd
Short-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Panacea Biotec Ltd
NSE:PANACEABIO
Short-Term Investments
â‚ą620.1m
CAGR 3-Years
-2%
CAGR 5-Years
62%
CAGR 10-Years
N/A
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
Short-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Transgene Biotek Ltd
BSE:526139
Short-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Z
Zenotech Laboratories Ltd
BSE:532039
Short-Term Investments
â‚ą216.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hester Biosciences Ltd
NSE:HESTERBIO
Short-Term Investments
â‚ą185m
CAGR 3-Years
163%
CAGR 5-Years
100%
CAGR 10-Years
N/A
Biocon Ltd
NSE:BIOCON
Short-Term Investments
â‚ą13.4B
CAGR 3-Years
-13%
CAGR 5-Years
4%
CAGR 10-Years
15%
No Stocks Found

Panacea Biotec Ltd
Glance View

Market Cap
26.5B INR
Industry
Biotechnology

Panacea Biotec Ltd. is a biotechnology company, which is engaged in the business of research, development, manufacture, and marketing of vaccines and pharmaceutical formulations. The company is headquartered in New Delhi, Delhi. The Company’s research areas include new chemical entities (NCE), new biological entities (NBE) novel drug delivery system (NDDS) based pharmaceutical formulations, novel peptides and human monoclonal antibodies and vaccine development. The Company’s product portfolio includes pain management, diabetes & cardiovascular management, oncology, renal disease management, osteoporosis management, anti-tubercular, gastrointestinal care products and vaccines. The Company’s subsidiaries include Panacea Biotec Pharma Limited, Panacea Biotec (International) SA, PanEra Biotec Private Limited and Meyten Realtech Private Limited.

PANACEABIO Intrinsic Value
178.94 INR
Overvaluation 59%
Intrinsic Value
Price

See Also

What is Panacea Biotec Ltd's Short-Term Investments?
Short-Term Investments
620.1m INR

Based on the financial report for Sep 30, 2024, Panacea Biotec Ltd's Short-Term Investments amounts to 620.1m INR.

What is Panacea Biotec Ltd's Short-Term Investments growth rate?
Short-Term Investments CAGR 5Y
62%

Over the last year, the Short-Term Investments growth was 72%. The average annual Short-Term Investments growth rates for Panacea Biotec Ltd have been -2% over the past three years , 62% over the past five years .

Back to Top